Bai et al. (2016) strongly supported that TOP3A was expected to be further exploited as a tumor suppressor and is of crucial importance for the diagnosis, treatment, and prognosis of patients with epithelial ovarian carcinoma [64]. The gene discussed is TOP3A; the disease is neoplasm.